<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Recommendations for Dual 510(k) and Clinical Laboratory Improvement Amendments Waiver by Application Studies; Guidance for Industry and Food and Drug Administration Staff; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Recommendations for Dual 510(k) and Clinical Laboratory Improvement Amendments Waiver by Application Studies; Guidance for Industry and Food and Drug Administration Staff; Availability</h1>
    <p class="timestamp">Published: 2020-02-26 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance entitled "Recommendations for Dual 510(k) and CLIA Waiver by Application Studies." It describes study designs for generating data that may support both 510(k) clearance and Clinical Laboratory Improvement Amendments (CLIA) waiver. Use of the Dual 510(k) and CLIA Waiver by Application pathway is optional; however, FDA believes this pathway is in many instances the least burdensome and fastest appro...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2020-03859</p>
    <p><strong>Publication Date:</strong> 2020-02-26</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2020/02/26/2020-03859/recommendations-for-dual-510k-and-clinical-laboratory-improvement-amendments-waiver-by-application">https://www.federalregister.gov/documents/2020/02/26/2020-03859/recommendations-for-dual-510k-and-clinical-laboratory-improvement-amendments-waiver-by-application</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2020-03859</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
